ABSTRACT: To site-specifically incorporate an unnatural amino acid (UAA) into target proteins in Escherichia coli, we use a suppressor plasmid that provides an engineered suppressor tRNA and an aminoacyl-tRNA synthetase (aaRS) specific for the UAA of interest. The continuous drive to further improve UAA incorporation efficiency in E. coli has resulted in several generations of suppressor plasmids. Here we describe a new, highly efficient suppressor plasmid, pUltra, harboring a single copy each of the tRNA and aaRS expression cassettes that exhibits higher suppression activity than its predecessors. This system is able to efficiently incorporate up to three UAAs within the same protein at levels up to 30% of the level of wild-type protein expression. Its unique origin of replication (CloDF13) and antibiotic resistance marker (spectinomycin) allow pUltra to be used in conjunction with the previously reported pEVOL suppressor plasmid, each encoding a distinct tRNA/ aaRS pair, to simultaneously insert two different UAAs into the same protein. We demonstrate the utility of this system by efficiently incorporating two bio-orthogonal UAAs containing keto and azido side chains into ketosteroid isomerase and subsequently derivatizing these amino acid residues with two distinct fluorophores, capable of Forster resonance energy transfer interaction. Finally, because of its minimal composition, two different tRNA/aaRS pairs were encoded in pUltra, allowing the generation of a single plasmid capable of dual suppression. The high suppression efficiency and the ability to harbor multiple tRNA/aaRS pairs make pUltra a useful system for conducting single-and multiple-UAA mutagenesis in E. coli.
T he ability to site-specifically incorporate unnatural amino acids (UAAs) into proteins in living cells significantly improves our ability to manipulate protein structure and function. 1 An engineered tRNA/aminoacyl-tRNA synthetase (aaRS) pair is used to insert the UAA of interest in response to a nonsense or frameshift codon. In Escherichia coli, two different tRNA/aaRS pairs (Methanocaldococcus jannaschii tyrosyl and Methanosarcina barkeri and Methanosarcina mazei-derived pyrrolysyl) have been engineered to genetically encode a large number of UAAs with a variety of novel functions, including amino acids with unique chemical reactivities, as well as metal binding, photo-cross-linking, photocaged, and fluorescent amino acids. 1 While this technique has been expanded to Saccharmoyces cerevisiae, 2 Pichia pastoris, 3 and mammalian cells, 4−7 E. coli remains an attractive expression host because of its robustness, facile manipulation, high levels of protein expression, and the large set of available genetically encoded UAAs. 1 To express a protein of interest containing a desired UAA at a specific site in E. coli, an expression plasmid encoding its corresponding nonsense or frameshift mutant is cotransformed with a suppressor plasmid that harbors the tRNA/aaRS pair, specific for the desired UAA. An early version of this suppressor plasmid employed an lpp promoter and a glnS promoter to express the tRNA and aaRS, respectively. 8 To improve the suppression efficiency of this system, a secondgeneration suppressor plasmid pSup 9 was developed with an enhanced glnS′ promoter to increase the level of synthetase expression and six copies of the tRNA expression cassette under the proK promoter. A variation of this plasmid, pSUPAR, 10 that harbored an additional araBAD-driven aaRS expression cassette and three copies of the tRNA driven by proK was also generated. Further optimization of this system yielded pEVOL, 11 which harbored one copy of the tRNA expression cassette under the efficient proK promoter and two copies of the aaRS under araBAD and glnS promoters (Figure 2a ). This latter vector resulted in a substantial improvement in suppression efficiency, approaching expression levels of the wild-type protein (without nonsense suppression), when used in conjunction with the efficient tRNA/aaRS pairs derived from the M. jannaschii tyrosyl (MjTyr) system. 11 However, when less efficient tRNA/aaRS pairs are used, the suppression efficiency of pEVOL decreases, indicating possible room for improvement.
In addition to the incorporation of a single UAA, the availability of mutually orthogonal tRNA/aaRS pairs, suppressing distinct codons in E. coli, has made possible the site-specific incorporation of multiple, different UAAs into the same protein. 12−16 To express proteins containing multiple, distinct UAAs, the relevant suppressor tRNA/aaRS pairs must be coexpressed with the target gene containing appropriately positioned nonsense and/or frameshift codons specifying the sites for UAA insertion. An efficient suppressor plasmid that allows the expression of multiple tRNA/aaRS pairs would facilitate the incorporation of multiple UAAs; however, the requirement for multiple copies of the tRNA or aaRS expression cassettes in the existing suppressor plasmids significantly complicates the integration of multiple tRNA/ aaRS pairs within the same vector.
Here we report the construction of a new suppressor plasmid, pUltra, which uses a single copy each of the tRNA and aaRS expression cassettes yet exhibits enhanced suppression efficiency relative to that of its most efficient counterpart, pEVOL. Using a pUltra plasmid expressing a tRNA/aaRS pair derived from the MjTyr system, suppression of three different amber stop codons within GFP was achieved with good efficiency. The pyrrolysyl-tRNA/aaRS pair was optimized for enhanced ochre (TAA) suppression and was also encoded in the pUltra plasmid. Together with the amber (TAG) suppressing MjTyr-tRNA/aaRS pair encoded in the pEVOL plasmid, this system was used to incorporate two different UAAs into the same protein in good yields. Furthermore, the simple composition of pUltra facilitated the generation of a dual suppressor plasmid that encodes both the ochre suppressing M. barkeri pyrrolysyl and the amber suppressing M. jannaschii tyrosyl tRNA/aaRS pairs.
■ MATERIALS AND METHODS
The DH10B (Life Technologies, Carlsbad, CA) strain of E. coli was used to clone or propagate plasmid DNA. The Qiagen (Valencia, CA) spin miniprep kit was used to purify plasmid DNA, while Macherey-Nagel (Bethlehem, PA) Nucleospin columns were used to purify DNA following digestion or gel electrophoresis. Platinum pfx DNA polymerase (Life Technologies) was used to perform polymerase chain reaction (PCR). Agilent QuikChange Lightning Site-Directed or Multi Site-Directed mutagenesis kits were used to generate single or multiple site-directed mutations, respectively. DNA oligomers for PCRs were purchased from IDT (Coralville, IA). The list of oligomers used in this report can be found in the Supporting Information. Restriction enzymes and T4 DNA ligase from NEB (Ipswich, MA) were used. Antibiotics, isopropyl β-D-1-thiogalactopyranoside (IPTG), and L-arabinose were purchased from Sigma-Aldrich (St. Louis, MO) and Fisher Scientific (Waltham, MA). Alexa Fluor 488 C 5 -aminooxyacetamide, Click-IT Alexa Fluor 488 DIBO Alkyne, and Alexa Fluor 594 DIBO Alkyne were obtained from Life Technologies. Bacteria were grown on LB/agar plates and 2×YT or TB liquid medium with the following antibiotic concentrations unless otherwise mentioned: 50 μg/mL kanamycin, 50 μg/mL spectinomycin, 50 μg/mL chloramphenicol, and 100 μg/mL ampicillin. Components of media were obtained from BD-Difco (Franklin Lakes, NJ) and Corning-Mediatech, Inc. (Manassas, VA). Synthesis of the MbPylRS gene with codon optimization for E. coli was conducted by GenScript (Piscataway, NJ).
Construction of pUltra, pEVOLtac, and pUltraII Vectors. The Clodf13 replicon, spectinomycin resistance cassette and the lacI gene of pUltra were derived from pCDF-1b. To construct pUltra, the T7 promoter/terminator elements in pCDF-1b (Novagen) were first replaced with a tacI promoter sequence followed by a multiple-cloning site. This was achieved by incorporating the corresponding insert DNA between the MluI and BsaAI restriction sites of pCDF-1b. The insert DNA was generated by overlap-extension PCR of two fragments, obtained using primers CDF-Mlu-F/CDFi-R and CDF-Bsa-R/CDFi-F and pCDF-1b as the template. Next, the rrnB terminator element was amplified via PCR from pEVOL using primers rrnB-Not-F and rrnB-Sbf-R, and inserted between the NotI and SbfI restriction sites downstream from the tacI promoter, to generate pUltra-basic. The proKtRNA CUA MjTyr cassette was amplified from pEVOL using primers proK-F and proK-R and inserted between the SbfI and NcoI restriction sites of pUltra-basic. Inserts for other tRNAs were generated by overlap-extension PCR of two fragments, obtained using this plasmid as the template and a combination of primers proK-F/tRNA-R and proK-R/tRNA-F. These fragments were then inserted into pUltra-basic using the same strategy. Following the introduction of the tRNA into pUltra-basic, the corresponding aaRS was amplified using primers RS-F and RS-R and inserted using the NotI restriction site downstream of the tacI promoter to generate the corresponding pUltra. To generate pUltra-Pro, Pyrococcus horikoshii ProRS variant PhPRS CUA -h1 was used. 23 For pUltra-Trp, S. cerevisiae Trp-tRNA AS3.5 was used along with wild-type ScTrpRS. The ochre suppressor pUltra-pyrrolysine was generated by site-directed mutagenesis of the corresponding amber suppressor vector using primers MmPylT-TAA-F and MmPylT-TAA-R. The U25C mutant of MmPylT was generated by site-directed mutagenesis using primers MmPylT-U25C-F and MmPylT-U25C-R.
To construct pEVOLtac, a DNA insert encoding the lacI gene, the tacI promoter, and rrnB terminator elements was amplified from pUltra-basic (using primers U2Ev-F and -R) and was inserted into the pEVOL plasmid using restriction sites HindIII and XhoI (removing the endogenous synthetase expression cassettes and the araC gene encoded in pEVOL).
To construct pUltraII, the aaRS and the tRNA expression cassettes were amplified from pUltra-MjTyr (pAcF-specific) using primers tacI-SalI-F and tRNA-XhoI-R. This DNA fragment was digested with SalI and XhoI and inserted into the XhoI restriction site of pUltra-Pyl TAA (encoding MbPylR-S opt and tRNA UUA
PylU25C
). Construction of Expression Plasmids. pET101-GFP (wild type and Tyr151TAG) was constructed as described previously. 11 The triple amber mutant of GFP was constructed by site-directed mutagenesis of pET101-GFP using gfpTAGm-3 and gfpTAGm-151.153. GFP-3TAG-151TAA was generated by site-directed mutagenesis of pET101-GFPwt using gfpTAGm-3 and gfpTAAm-151.
Analysis of Aminoacyl-tRNA Synthetase Expression. pBK-tacI-MjTyrRS-(His) 6 , pBK-tacI-MbPylRS-(His) 6 , and pBK-tacI-MbPylRS(opt)-(His) 6 were transformed into DH10B E. coli by electroporation. An overnight culture of these cells was used to inoculate 25 mL of 2×YT medium supplemented with 50 μg/mL kanamycin at an OD 600 of 0.05. At an OD 600 of 0.7, the cultures were cooled from 37 to 30°C for 16−24 h. Cells were harvested by centrifugation and lysed using BugBuster Protein Extraction Reagent (EMD-Millipore, Billerica, MA) supplemented with Complete Mini EDTA-free protease inhibitor cocktail (Roche, Indianapolis, IN), 0.5 mg/ mL lysozyme (MP Biomedicals, Solon, OH), and 5 units/mL Benzonase Nuclease (Novagen) according to the manufacturer's instructions. Following lysis, cell debris was removed by centrifugation at 18000g. Cell free extract, the insoluble fraction, and the soluble fraction were separated via reducing sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS−PAGE) (Novex 4 to 20% Tris-glycine, Invitrogen), transferred to nitrocellulose, and probed with a 1:1000 dilution of anti-His 6 -HRP (Clontech, Mountain View, CA). Blots were developed using SuperSignal West Dura Chemiluminescent substrate (Pierce) and exposed to film.
Expression, Purification, and Mass Spectrometry (MS) Analyses of Reporter Proteins. GFP expression was performed as described previously. 11 In summary, E. coli BL21(DE3) carrying the expression plasmid and the suppressor plasmid (pEVOL, pEVOLtac, pUltra, or pUltraII) was grown in rich medium (2×YT or TB) until the OD 600 reached 0.6−0.8, at which point the expression of the target gene and the synthetase were co-induced with 1 mM IPTG (for pEVOLtac, pUltra, and pUltraII) or 1 mM IPTG and 0.02% L-arabinose (for pEVOL). The relevant UAAs were also added at this point to a final concentration of 1 mM. Protein expression was continued for 10−14 h at 37°C. For rapid analysis of GFP expression, cells from a 100 μL culture were resuspended in 200 μL of PBS (Mediatech) and transferred to 96-well black clear bottom assay plates, and GFP fluorescence was measured using a SpectraMax GeminiEM plate reader (Molecular Devices). Fluorescence readings were normalized by dividing by OD 600 .
To isolate overexpressed proteins, cells from a 10−40 mL culture were harvested by centrifugation, resuspended in 0.5−2 mL of BugBuster Protein Extraction Reagent supplemented with Complete Mini EDTA-free protease inhibitor cocktail, 0.5 mg/mL lysozyme, and 5 units/mL Benzonase Nuclease, and incubated on ice for 15 min. The lysate was clarified by centrifugation at 18000g for 15 min, and the His 6 -tagged protein (C-terminal) was isolated using Qiagen Ni-NTA Agarose Superflow resin according to the manufacturer's instructions. The molecular weights of purified proteins were verified using electrospray ionization mass spectrometry (ESI-MS) analysis.
Site-Specific Conjugation of Alexa Fluor 488 to GFPpAcF3-AzK151. GFP-3TAG-151TAA was expressed from the pET101 plasmid, and pEVOL-pAcF and pUltra-Pyl TAA were used to suppress the amber and ochre codons with pAcF and AzK, respectively. Protein expression and purification were performed as described above. For the ketone−hydroxylamine conjugation reaction, the purified protein was concentrated to 60 μM and buffer-exchanged into 100 mM sodium acetate buffer (pH 4.5) using Micro Bio-Spin 6 desalting columns (BioRad, Hercules, CA), following the manufacturer's instructions. To 25 μL of protein were added Alexa Fluor 488 C 5 -aminooxyacetamide and p-methoxyaniline at final concentrations of 300 μM and 100 mM, respectively. For the azido− cyclooctyne conjugation reaction, the purified protein was concentrated to 60 μM and buffer-exchanged into DPBS (Gibco) using Micro Bio-Spin 6 desalting columns (Bio-Rad), following the manufacturers' instructions. To 25 μL of protein was added Click-IT Alexa Fluor 488 DIBO Alkyne at a final concentration of 300 μM. Both reactions were allowed to proceed overnight (14 h) at 37°C in the dark, and the mixtures were subsequently resolved by SDS−PAGE. Protein bands were detected by Coomassie staining, while fluorescence was detected using UV transillumination using a Bio-Rad ChemiDoc XRS imaging system.
Site-Specific Double Labeling of KSI-AzK7-pAcF78 with Alexa Fluor 488 and 594. KSI-7TAA-78TAG was expressed from the pET28 plasmid using pUltra-Pyl TAA and pEVOL-pAcF to suppress the ochre and the amber codons with AzK and pAcF, respectively. Protein expression and purification were performed as described above. The purified protein was buffer-exchanged into 100 mM sodium acetate buffer (pH 4.5) using an Amicon Ultra-15 3 kDa molecular weight cutoff (MWCO) membrane filter and concentrated to 50 μM. To 100 μL of this protein was added Alexa Fluor 488 C 5 -aminooxyacetamide at a final concentrations of 500 μM, and the conjugation reaction was allowed to proceed overnight at 37°C in the dark. The protein−dye conjugate precipitated under the reaction conditions, was washed with PBS, and was dissolved in 100 μL of 8 M urea. At this point, Alexa Fluor 594-DIBO was added at a final concentration of 300 μM to the protein, and the reaction mixture was incubated overnight at 37°C in the dark. The doubly labeled protein was refolded via rapid dilution into 15 mL of ice-cold DPBS containing 5 mM β-mercaptoethanol and overnight incubation in the dark at 4°C
. The protein was concentrated, and the excess fluorophore was removed using an Amicon Ultra-15 3 kDa MWCO membrane filter. Doubly labeled protein was analyzed by MS, absorbance, and fluorescence spectroscopy.
■ RESULTS AND DISCUSSION
Construction of pEVOLtac and pUltra. The expression levels of the suppressor tRNA and the corresponding aaRS can be modulated by the choice of the promoters used to drive their transcription and the number of copies of each expression cassette encoded in the suppression plasmid. During the construction of pEVOL, the most efficient suppressor plasmid available to date, 11 it was found that a single expression cassette of the tRNA driven by the efficient proK promoter provides robust suppression efficiency, which did not significantly improve upon the inclusion of additional copies of the tRNA gene. However, the presence of two expression cassettes of the aaRS, expressed from a constitutive weak promoter (glnS) and an inducible strong promoter (araBAD), was crucial for achieving high suppression levels. 11 Some inducible promoters allow low levels of leaky expression in the absence of the inducer, 17, 18 which may mimic the expression pattern of the aaRS from pEVOL. One promising candidate is the tacI promoter, 19 a hybrid of lacUV and trp promoters, which can be repressed by LacI and can be derepressed with IPTG. Like lacUV, this promoter shows residual leaky activity in the absence of the inducer (IPTG), especially in a rich culture medium (e.g., LB). We replaced the two aaRS expression cassettes of pEVOL with a single copy of the tacI-driven expression cassette of an MjTyrRS variant, specific for pacetylphenylalanine [pAcF (Figure 1 )], to generate suppressor plasmid pEVOLtac (Figure 2a) . A strong ribosome binding site sequence (AAGGAG) was inserted preceding the start codon, and the rrnB transcription−termination sequence from pEVOL was introduced following the aaRS. The original proK-driven Mj-tRNA CUA Tyr expression cassette in pEVOL was retained in the new plasmid. Also, repressor element araC in pEVOL was replaced with lacI to allow IPTG inducible expression of the aaRS from the tacI promoter.
Traditionally, the suppressor plasmid is constructed using a low-copy number p15a (10−12 copies per cell)-derived origin of replication (ori) to allow compatibility with colE1-or pBR322-derived origins, which is used in the vast majority of the common E. coli protein expression vectors (e.g., pET, pBAD, pQE, etc.). Other ori's that are mutually compatible with both p15a and colE1 are now available. 20, 21 A suppressor plasmid that uses such a rare ori would further expand its compatibility with commonly used expression vectors and facilitate its comaintenance with two additional, distinct plasmids, required for specific applications. Furthermore, CloDF13 (cdf), 20 one such available ori, maintains a higher copy number (20−40 copies per cell) in E. coli, which may enhance the expression level of the tRNA/aaRS pair and, consequently, the suppression efficiency. Therefore, a second suppressor plasmid, pUltra, was generated by inserting expression cassettes tacI-MjYRS (pAcF) and proK-tRNA CUA Tyr into the pCDF vector, which encodes the cdf ori, a spectinomycin antibiotic resistance gene and a LacI expression cassette for inducible expression of the aaRS from the tacI promoter (Figure 2a) .
Evaluation of the Suppression Efficiencies of pEVOLtac and pUltra. The previously reported GFP (Tyr151-TAG) 11 mutant was used to evaluate the suppression efficiencies of the new suppressor plasmids. Upon suppression of the amber stop codon, full-length GFP is produced, allowing rapid assessment of suppression levels based on GFP fluorescence. Also, the inherently low suppression efficiency of this mutant provides a broader dynamic range for the optimization of the suppression machinery. The new suppressor plasmids, pEVOLtac and pUltra, harboring MjTyrRS (pAcF) and tRNA CUA Tyr , were cotransformed with pET101-GFP (Tyr151TAG) into the BL21(DE3) strain of E. coli, and the expression level of GFP was analyzed in the presence and absence of pAcF in terrific broth (TB). For comparison, the corresponding pEVOL vector was also used to express the same GFP mutant, using optimal expression conditions reported above.
The suppression efficiencies of pEVOL and pEVOLtac were comparable, suggesting that the single tacI-driven aaRS expression cassette can efficiently replace the two expression cassettes in pEVOL (Figure 2b) . The expression level afforded by pUltra was approximately 30% higher than both, possibly because of the higher copy number sustained by its ori ( Figure  2b ). Recently, a polyspecific MjTyrRS has been described, 22 originally selected to charge p-cyanophenylalanine (pCNF), which can be used to incorporate a large number of UAAs into target proteins. This synthetase was inserted into pUltra, and the ability of the corresponding suppressor plasmid to suppress the GFP-Tyr151TAG mutant was verified using pAcF, Omethyltyrosine [OMeY (Figure 1) ], p-azidophenylalanine [pAzF (Figure 1) ], and p-nitrophenylalanine [pNO 2 -F ( Figure  1) ]. In each case, the GFP expression level was compared to that obtained with the corresponding pEVOL plasmid ( Figure  2c ). As observed with the pAcF-specific suppressor systems, pUltra consistently provided higher suppression levels (between 20 and 50%). We also monitored the postinduction expression levels of GFP (Tyr151TAG) in a time-dependent manner, using pEVOL and pUltra encoding the pAcF-specific MjTyrRS. Significantly faster expression kinetics was observed with pUltra ( Figure 2d ). The expression level of GFP reached saturation within 5−7 h of induction using pUltra for amber suppression, compared to 10−14 h for pEVOL.
The amber suppression efficiencies exhibited by pEVOL vectors encoding MjTyr-derived tRNA/aaRS pairs are high, approaching the wild-type protein expression levels (without amber suppression) in some instances. 11 Consequently, the dynamic range for the evaluation of the efficiency of new suppressor vectors is limited. Therefore, a new GFP expression cassette was generated carrying three amber mutations at permissive sites (GFP-3*). Only when all three amber codons are suppressed will full-length GFP be produced. When we expressed this construct using pEVOL and pUltra plasmids, both encoding the aforementioned pAcF-specific or polyspecific MjTyrRS (tested with OMeY), 200−300% improvements in expression levels were observed for pUltra ( Figure  3a) . This difference in suppression efficiency between the two suppressor plasmids is significantly greater than that observed using the GFP construct with a single amber codon (Tyr151TAG) and demonstrates the higher efficiency of pUltra relative to that of pEVOL. The protein was purified, and incorporation of three UAAs was confirmed by MS analysis.
Yields for GFP-3* with pUltra-pAcF (∼5 mg/L) were approximately 30% of the same for wtGFP (without amber suppression).
The suppression efficiencies of pEVOL and pUltra were further evaluated with two other tRNA/aaRS pairs recently adapted in E. coli for amber suppression: an archaebacteriumderived prolyl-tRNA (Archaeoglobus f ulgidus)/ProRS (P. horikoshii) pair 23 and a S. cerevisiae-derived tryptophanyltRNA/TrpRS pair. 24 These systems are significantly less efficient than the optimized MjTyr-derived pair, and when expressed from pEVOL, they afford low expression levels of GFP (Tyr151TAG) upon amber suppression (<5% of wtGFP). A 10−15-fold improvement in suppression efficiency was observed (10−15-fold) when the corresponding pUltra plasmids encoding the prolyl or tryptophanyl pair were used to express the same GFP construct in either case (Figure 3b) . These results suggest that pUltra is a more efficient suppressor system than pEVOL and is particularly useful for UAA mutagenesis of weakly suppressing target proteins or when a weak suppressor tRNA/aaRS pair is used.
Finally, the suppression efficiencies of the pUltra plasmids encoding the pAcF-specific and polyspecific MjYRS were further verified with T4 lysozyme (Asn68TAG) and ketosteroid isomerase (His78TAG) expression plasmids. Efficient protein expression was observed in both cases, and the yields were approximately 50% relative to the corresponding wild-type proteins [without amber suppression ( Figure S1 of the Supporting Information)]. All protein expressions were performed in shake flasks in 2×YT medium.
Optimization of an Ochre Suppressor Pyrrolysyl tRNA/aaRS Pair. The archaebacterium-derived pyrrolysine tRNA/aaRS pair has been engineered to genetically encode a large number of UAAs. 1 It was shown that this pair is anticodon permissive 25 and efficiently suppresses ochre (TAA) codons. 14, 15 It is also orthogonal to the amber-suppressing MjTyr-derived tRNA/aaRS pairs and can be used together to incorporate two different UAAs into the same protein.
14, 15 The use of this dual-suppression system should be facilitated by pUltra, which encodes a unique ori and antibiotic resistance marker and should allow the simultaneous use of two different suppression vectors for the introduction of two distinct UAAs into a target protein. The pyrrolysyl (ochre) and MjTyr (amber) suppression systems can be encoded by pUltra (cdf ori, spectinomycin marker) and pEVOL/pEVOltac (p15a ori, chloramphenicol marker), respectively, and the target gene can be encoded in a common expression vector (colE1 ori, antibiotic selection marker other than spectinomycin and chloramphenicol); all three plasmids can be comaintained in E. coli. The modular nature of this dual-suppression system eliminates the need to generate complicated expression plasmids.
To evaluate the suppression efficiency of the pyrrolysyl system, we constructed pUltra plasmids harboring amber suppressor tRNA CUA Pyl (M. mazei)/PylRS (M. barkeri) pair or its ochre suppressor counterpart, Mm-tRNA UUA Pyl /MbPylRS. The suppression efficiencies of these plasmids were tested with the GFP (Tyr151TAG or TAA) expression vectors using ε-tBoc-lysine [eBK (Figure 1) ], a UAA that is efficiently charged by MbPylRS. 1 While the GFP expression levels in both cases were similar, the suppression efficiencies were found to be nearly 10-fold lower than the same observed for the MjTyrderived suppressor pairs (Figure 4c) . One of the factors contributing to this lower activity was found to be the lower Figure 3 . Comparison of suppression efficiencies of pUltra and pEVOL for GFP-3* using the MjTyr pair or for GFP-151TAG using the less efficient tRNA/aaRS pairs. (a) Expression of full-length GFP from pET-GFP-3* with three in-frame amber stop codons, using pUltra or pEVOL (encoding either a pAcF-specific or a polyspecific MjTyr tRNA/aaRS pair). The top panel shows GFP expression as normalized fluorescence, in the presence or absence of the corresponding UAA (OMeY was used for the polyspecific synthetase). The bottom panel shows the SDS−PAGE analysis of isolated protein expressed using the pAcF-specific pEVOL or pUltra in the presence (+) or absence (−) of pAcF. (b) Expression levels of GFP from pET-GFP(Y151TAG) using the pUltra or pEVOL vector encoding the engineered tryptophanyl or prolyl suppressor tRNA/aaRS pairs (charging tryptophan or proline, respectively). The top panel shows normalized fluorescence and the bottom panel SDS−PAGE analysis of the isolated protein from each expression experiment. expression levels of MbPylRS compared to those of MjTyrRS. When MjTyrRS was expressed from the tacI promoter, strong expression could be observed using a Western blot (Figure 4a,  lane 7) , while the same experiment with MbPylRS failed to detect any protein (Figure 4a, lanes 1−3) . Replacing the original copy of the MbPylRS gene with a variant codonoptimized for expression in E. coli resulted in improved expression levels (Figure 4a, lanes 4−6) . When introduced into pUltra in conjunction with the ochre-suppressing MmtRNA UUA Pyl , MbPylRS(opt) exhibited a ∼2-fold increase in its suppression efficiency relative to that of pUltra harboring the original MbPylRS gene (Figure 4) . It is worth noting that the increase in synthetase expression levels did not correlate with the increase in suppression efficiency. This may be due to improper folding of MbPylRS in E. coli, leading to an inactive protein. The majority of the expressed MbPylRS was found in the insoluble fraction (Figure 4a , lane 5), consistent with this hypothesis.
To further enhance the suppression efficiency of this pair, we attempted to improve the activity of tRNA Pyl . It has previously been shown that the presence of the G:U wobble pair in the stem regions of a tRNA leads to suboptimal activity, which is often improved by a G:C substitution. 26 For the Mm-tRNA Pyl , we identified such a G:U wobble pair in the anticodon stem (Figure 4b) . A U25C mutant of tRNA UUA Pyl was generated, substituting this wobble pair with a G:C pair, and incorporated into pUltra along with the MbPylRS(opt). When the suppression efficiency of this vector was tested with the aforementioned GFP (Tyr151TAA) expression construct, a further 2-fold increase in suppression efficiency was observed relative to that of the corresponding pUltra plasmid with wildtype tRNA UUA Pyl (Figure 4c,d) . The suppression efficiency of this optimized pyrrolysyl pair, comprising MbPylRS(opt) and tRNA UUA Pyl (U25C), is significantly improved relative to that of its wild-type counterparts and should be useful for enhanced expression of mutant proteins.
A Facile System for Suppression with Two Distinct UAAs. The development of a pUltra suppressor plasmid encoding an improved ochre-suppressing pyrrolysyl pair should facilitate the incorporation of two distinct UAAs into the same protein.
To investigate the potential of this system, we generated a GFP expression plasmid that encodes a GFP-3TAG-151TAA double mutant. This plasmid was cotransformed with pUltra (encoding MbPylRS o p t and tRNA UUA PylU25C ; pUltra-Pyl TAA ) and pEVOL (encoding a pAzF-specific MjTyrRS/tRNA CUA Tyr ) suppressor plasmids into strain BL21(DE3). The ability of the resulting bacteria to express full-length GFP by dual suppression was investigated in rich medium. No detectable GFP was produced when neither of the UAAs or only pAzF was present. Low levels of expression could be observed in the presence of eBK alone (Figure 5a ). This is consistent with the observation that in the absence of its cognate UAA, MjTyr-derived tRNA/aaRS pairs exhibit higher background suppression levels than their pyrrolysine counterparts. However, when the cognate UAA is present, the fidelity of incorporation of the UAA into the target protein by the MjTyr pair is high. In the absence of eBK, little background suppression is observed with the highly orthogonal Figure 4 . Optimization of the pyrrolysyl pair. (a) Codon optimization improves the expression level of MbPylRS. The His 6 -tagged aaRS gene under the tacI promoter is expressed in E. coli, and protein in the lysate is detected by Western blotting. In lanes 1−3, for the wild-type MbPylRS gene, the abundance of synthetase in the crude lysate, the insoluble fraction, and the soluble fraction, respectively, is shown. In lanes 4−6, for the codon-optimized MbPylRS gene, the abundance of synthetase in the crude lysate, the insoluble fraction, and the soluble fraction, respectively, is shown. Lane 7 shows the expression level of the wild-type His 6 -tagged MjTyrRS in a similar experiment for reference. (b) Pyrrolysyl-tRNA contains an unfavorable U:G wobble pair in the anticodon stem, which was mutated to a C:G pair to improve suppression efficiency. (c) Suppression efficiencies of different pyrrolysyl-tRNA/aaRS pairs (in pUltra), measured as the expression level of GFP (normalized fluorescence) from pET-GFP(Y151TAG) or pET-GFP(Y151TAA) in the presence (yellow) or absence (red) of eBK. TAG-wt and TAA-wt represent pUltra vectors harboring amber-and ochre-suppressing wild-type pyrrolysine pairs, respectively. TAA-OptRS represents the combination of wildtype ochre suppressor tRNA and codon-optimized MbPylRS, while TAA-OptRS-tRNAU25C represents the combination of the U25C mutant of the ochre suppressor tRNA and codon-optimized MbPylRS. (d) Isolated protein samples expressed from pET-GFP(Y151TAA) using pUltra vectors, encoding the three different combinations of ochre-suppressing pyrrolysyl pairs described above, in the presence (+) or absence (−) of eBK. pyrrolysyl pair. Robust production of GFP (6 mg/L; ∼33% of that of wtGFP) was observed only in the presence of both pAzF and eBK (Figure 5a ). The protein was isolated using a Cterminal hexahistidine tag and characterized by ESI-MS analysis, which revealed a homogeneous species, incorporating both pAzF and eBK (Figure 5a,b) . Wild-type MbPylRS is also able to accept several other UAAs, including AzK and AlkK (Figure 1) , which contain functional groups allowing bioorthogonal conjugation reactions. Using the same conditions described above, pAzF and AlkK were also incorporated into distinct sites in GFP in good yields (4 mg/L, ∼22% of that of wtGFP), and the mass of the purified protein sample was confirmed by MS analysis ( Figure S2a and Table S1 of the Supporting Information).
To further demonstrate the utility of this system, we replaced the pEVOL-pAzF plasmid in this experiment with its counterparts encoding the aforementioned pAcF-specific or polyspecific MjTyrRS. Using pEVOL-pAcF and pUltra-Pyl TAA , pAcF was incorporated into GFP at TAG3, along with eBK (4 mg/L), AlkK (0.5 mg/L), or AzK (5 mg/L) at TAA151 ( Figure  S2b of the Supporting Information). In each case, the fulllength mutant protein was purified and verified by MS analysis (Table S1 of the Supporting Information). The combination of pEVOL (polyspecific MjTyrRS) and pUltra-Pyl TAA is especially versatile, as it can be used to incorporate various combinations of UAAs that are substrates for the respective synthetases. This was demonstrated by simultaneously incorporating pAcF and AzK, pAcF and eBK, pAzF and eBK, and OMeY and eBK into TAG3 and TAA151 of GFP-3TAG-151TAA, respectively ( Figure S2d of the Supporting Information). Full-length protein in each case was purified using the C-terminal hexahistidine tag (yields between 3 and 5 mg/L) and verified by MS analysis (Table S1 of the Supporting Information). The background suppression efficiency of the polyspecific MjTyrRS, in the absence of cognate UAAs, is somewhat higher than those of other engineered MjTyrRS variants. This was reflected in the control experiments for dual suppression using this plasmid, in which only the MbPylRS-specific UAA was added ( Figure S2 of the Supporting Information). However, MS analyses showed homogeneous incorporation of the desired UAAs, when both were present in the expression medium (Table S1 of the Supporting Information).
Introduction of a Forster Resonance Energy Transfer (FRET) Pair by Dual Suppression. The ability to introduce two different bio-orthogonal UAAs into the same protein allows the modification of the protein with two distinct small molecules or macromolecular moieties.
12−16 Using the strategy described above, a GFP double mutant that simultaneously incorporates pAcF (TAG3) and AzK (TAA151) in good yield [5 mg/L, ∼30% of the wtGFP yield (Figure 6a,b) ] was expressed. To demonstrate the competence of the ketone and azide groups in this protein for site-specific conjugation reactions, we coupled the protein independently to Alexa To simultaneously install two different fluorophores capable of FRET into a single protein by two bio-orthogonal conjugation reactions, a nonfluorescent protein target, ketosteroid isomerase (KSI), was used. On the basis of an available crystal structure (Protein Data Bank entry 1W00), two proximal residues in the folded form of this protein, Gln7 and His78, were chosen for the installation of the FRET pair. The double mutant (KSI-7TAA-78TAG) encoded in a pET28 expression plasmid was cotransformed with pEVOL-pAcF and pUltra-Pyl TAA into the BL21(DE3) strain of E. coli. Expression of the mutant KSI was conducted by dual suppression, incorporating eBK or AzK at TAA7 and pAcF at TAG78. The full-length protein was purified using a C-terminal hexahistidine tag (isolated yields of 34 and 20 mg/L for eBK/pAcF and AzK/pAcF mutants, respectively) and verified by MS analysis (Figure 7a,b) . To the AzK/pAcF mutants of KSI Alexa Fluor 488-hydroxylamine and Alexa Fluor 594-DIBO (containing a strained cyclooctyne) were conjugated sequentially the ketone and azide groups of pAcF and AzK, respectively. Successful conjugation was verified by SDS− PAGE analysis followed by fluorescence imaging and Coomassie staining (Figure 7c) , and by MS analysis ( Figure  S3 of the Supporting Information). While the Alexa Fluor 488-hydroxylamine conjugation reaction went to near completion (>95%), the yield of the Alexa Fluor 594-cyclooctyne conjugation reaction was approximately 80%. The latter is due to the partial reduction of the azide to an amine during protein expression in vivo, as observed by MS analysis (Figure 7b and Figure S3 of the Supporting Information). FRET between the two fluorophores was verified by exciting Alexa Fluor 488 at 480 nm. While the Alexa Fluor 488 singly labeled protein had an emission maximum of 520 nm, the dual-labeled protein showed a second emission peak with a maximum at 620 nm (Figure 7e ). The excitation spectrum of the latter peak revealed two absorption maxima, one consistent with the excitation of Alexa Fluor 488 and the second with excitation of Alexa Fluor 594 (Figure 7e ), confirming FRET between the two fluorophores.
Generation of a Dual-Suppressor Plasmid pUltraII. The simple composition of pUltra, comprising one expression cassette each of the synthetase and tRNA, should facilitate the integration of both the tyrosyl and the pyrrolysyl suppression systems into a single suppressor plasmid. To construct such a vector, we incorporated the expression cassettes for the aaRS and the tRNA from pUltra-pAcF into pUltra-Pyl TAA to generate pUltraII (Figue 8a). This plasmid encodes all of the elements of the amber-suppressing MjTyr pair and the ochre-suppressing pyrrolysine pair. To test the ability of this plasmid to conduct dual suppression, the previously described GFP-3TAG-151TAA expression plasmid was used. The suppressor and expression plasmid were cotransformed into the BL21(DE3) strain of E. coli, and the expression of GFP-3TAG-151TAA was attempted in TB medium using eBK and pAcF to suppress the ochre and amber codons, respectively. For comparison, the corresponding three-component system for dual suppression, using the pUltra-Pyl TAA and pEVOL-pAcF suppressor plasmids, was also tested. Both systems exhibited similar levels of expression of full-length GFP [∼3−4 mg/L, 20−25% of that of wtGFP (Figure 8b) ]. Thus, pUltraII provides a platform for efficient integration of multiple suppression systems to facilitate two or more UAAs to the same protein.
■ CONCLUSIONS
Here we have generated a highly efficient suppression system, consisting only of one expression cassette each for the tRNA and aaRS. This minimal suppressor system can be incorporated into vectors with different ori and antibiotic resistance markers, as demonstrated with pEVOLtac and pUltra, to generate highly efficient suppressor plasmids. In particular, pUltra exhibited enhanced suppression efficiency relative to the existing pEVOL vector and was especially useful when tested with weakly expressing mutants or inherently weak suppressor tRNA/aaRS pairs. The mutually compatible nature of pEVOL and pUltra was exploited to simultaneously incorporate two different UAAs into the same protein using the amber-suppressing MjTyr and the ochre-suppressing pyrrolysyl suppressor systems. Many other UAAs have been genetically encoded using the M. jannaschii tyrosyl-and archaeal pyrrolysyl-tRNA/ aaRS pairs; the dual-suppression system described here should allow facile incorporation of various combinations of these UAAs into target proteins without the construction of complex vectors. In addition, we have optimized the suppression efficiency of the ochre suppressor pyrrolysyl pair to enhance the efficiency of dual suppression. Finally, we demonstrated that pUltra can serve as a platform for the integration of two different tRNA/aaRS suppressor pairs to generate a single plasmid capable of dual suppression. The new vector systems described herein should provide valuable new tools for facilitating single-and multiple-UAA mutagenesis in E. coli.
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